These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11429786)

  • 1. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.
    Wang D; Russell J; Xu H; Johnson DG
    Mol Carcinog; 2001 Jun; 31(2):90-100. PubMed ID: 11429786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
    Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.
    Wang D; Russell JL; Johnson DG
    Mol Cell Biol; 2000 May; 20(10):3417-24. PubMed ID: 10779331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
    Pierce AM; Fisher SM; Conti CJ; Johnson DG
    Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.
    Pierce AM; Gimenez-Conti IB; Schneider-Broussard R; Martinez LA; Conti CJ; Johnson DG
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8858-63. PubMed ID: 9671769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
    Chen Q; Hung FC; Fromm L; Overbeek PA
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the transcription factor DP in apoptosis.
    Hitchens MR; Robbins PD
    Apoptosis; 2003 Oct; 8(5):461-8. PubMed ID: 12975577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of E2F transcription factors in chemically induced mouse skin tumors.
    Balasubramanian S; Ahmad N; Mukhtar H
    Int J Oncol; 1999 Aug; 15(2):387-90. PubMed ID: 10402252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
    Jones SJ; Dicker AJ; Dahler AL; Saunders NA
    J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model.
    Paulson QX; McArthur MJ; Johnson DG
    Cell Cycle; 2006 Jan; 5(2):184-90. PubMed ID: 16340309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new component of the transcription factor DRTF1/E2F.
    Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
    Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F.
    Nakajima R; Deguchi R; Komori H; Zhao L; Zhou Y; Shirasawa M; Angelina A; Goto Y; Tohjo F; Nakahashi K; Nakata K; Iwanaga R; Bradford AP; Araki K; Warita T; Ohtani K
    Biochem Biophys Res Commun; 2023 Jun; 663():154-162. PubMed ID: 37141667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Horizontal basal cell proliferation in the olfactory epithelium of transforming growth factor-alpha transgenic mice.
    Getchell TV; Narla RK; Little S; Hyde JF; Getchell ML
    Cell Tissue Res; 2000 Feb; 299(2):185-92. PubMed ID: 10741459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R; Cheng E; Smicun Y; Germino J
    J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model.
    Pierce AM; Schneider-Broussard R; Gimenez-Conti IB; Russell JL; Conti CJ; Johnson DG
    Mol Cell Biol; 1999 Sep; 19(9):6408-14. PubMed ID: 10454586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DP-1 transcription factor is required for keratinocyte growth and epidermal stratification.
    Chang WY; Bryce DM; D'Souza SJ; Dagnino L
    J Biol Chem; 2004 Dec; 279(49):51343-53. PubMed ID: 15448153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP.
    Park KK; Deok Ahn J; Lee IK; Magae J; Heintz NH; Kwak JY; Lee YC; Cho YS; Kim HC; Chae YM; Ho Kim Y; Kim CH; Chang YC
    Biochem Biophys Res Commun; 2003 Sep; 308(4):689-97. PubMed ID: 12927774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activities of E2F family members: unique functions in regulating transcription.
    Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
    Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.